RxDoctor Payments Data

Jean Dortilus, MD

Psychiatry · Waco, TXNPI 1063658524

Payments from drug & device makers

$2,966in general payments, 2019–2025

Across 144 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$661
  • Takeda Pharmaceuticals U.S.A., Inc.$584
  • Neuronetics, Inc.$575
  • Axsome Therapeutics, Inc.$323
  • Otsuka America Pharmaceutical, Inc.$274
  • Idorsia Pharmaceuticals US Inc$200
  • plus $350 from 6 others

What the payments were for

  • Food & beverage$2,86497%
  • Education$1023%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,966 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$31,639
Medicare patients
35
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelsomraSuvorexant23$10,081
Desvenlafaxine Succinate ErDesvenlafaxine Succinate58$3,863
Duloxetine Hcl87$2,549
Lisdexamfetamine Dimesylate13$2,069
Bupropion XlBupropion Hcl69$1,752
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine20$1,627
Trazodone Hcl84$1,534
Clonazepam171$1,353
Bupropion Hcl37$1,295
Venlafaxine Hcl ErVenlafaxine Hcl36$988
Mirtazapine56$899
Vilazodone Hcl13$777
Eszopiclone38$684
Zolpidem Tartrate79$663
Quetiapine Fumarate40$495

Paid to pharmacies, not to this prescriber.

Other psychiatry in Waco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →